Ebola in DR Congo: what the tally above 10,000 cases means
· BehindLines newsroom
The Ebola outbreak in the Democratic Republic of the Congo has now exceeded 10,000 confirmed cases. According to Congolese health authorities, figures as of 25 October show 10,060 confirmed cases and 4,887 deaths in the DRC. These totals appear in the US Centers for Disease Control and Prevention (CDC) table, on a page updated on 27 October, and in Britain's NaTHNaC health surveillance service.
A national cumulative total, not a daily count
These figures bring together confirmed cases recorded since the outbreak began. They represent neither infections on 27 October alone nor all cases across Africa. A page's update date and the date of its data answer different questions: when information was published, and how far the count extends.
Passing 10,000 cases describes the outbreak's cumulative scale; that threshold alone cannot show how quickly it is currently spreading.
Access to care remains a challenge
The World Health Organization (WHO) bulletin of 23 October describes continuing transmission in the DRC and difficulties with early detection. Of the 482 deaths added since its previous update, 307 occurred in communities and 175 in treatment centres. These observations predate the updated CDC table.
WHO says no vaccine or specific treatment is approved against Bundibugyo virus. The lack of an approved specific treatment does not mean care is unavailable. The organisation stresses rapid identification, laboratory testing, clinical care, contact tracing and community participation.
A vaccine trial whose results remain to be established
According to the Coalition for Epidemic Preparedness Innovations (CEPI), the first TUMAINI trial participant was vaccinated in Bunia on 23 October. This phase 2/3 study evaluates vaccine candidates, including Ervebo, which is already licensed against a different Ebola virus species.
CEPI says no vaccine is yet approved against Bundibugyo. Starting a trial establishes neither its efficacy nor protection already secured for the population. It begins an evaluation while the public health response must continue.